GNH USA

Europe — EMA

Ostacid (Alendronic Acid)

Alendronic acid, the active ingredient in Ostacid, is a bisphosphonate presented as a tablet for oral use. It treats osteoporosis and other bone loss conditions in post‑menopausal women and men at risk of fracture.

Request sourcing

1
Pack/s

What is Alendronic Acid?

Alendronic acid, the active ingredient in Ostacid, is a bisphosphonate presented as a tablet for oral use. It treats osteoporosis and other bone loss conditions in post‑menopausal women and men at risk of fracture. GNH USA supplies Ostacid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Alendronic Acid used for?

Ostacid is a bisphosphonate that acts on bone metabolism pathways. It is indicated for: - Osteoporosis: Reduces the risk of vertebral and hip fractures. - Paget’s disease of bone : Helps the normal to restore bone remodeling process of the ... . - Secondary hyper‑horm ... .

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Alendronic Acid
Route
Oral Use
Manufacturer
Williams & Halls Ehf
Origin
EU

Related products